You need to upgrade your Flash Player
 © 2016 Pansoft S.r.l.
Company
Solutions
Services
References
Partners
Contacts
News, announcements, information from Pansoft press office.

News

 


14/1/2008 - Press Review - About Pharma n.54

About Pharma, reference magazine in the pharmaceutical world, on its n. 54 of January 2008 publishes an interview with Dr. Salvatore Calabrese,
Vice-President Finance of Gentium S.p.A.

Gentium has entrusted to Pansoft to implement its new ERP information system, needed to win the challenges of legal, operational and organizational nature, which are typical for a biopharmaceutical company that, in addition to the industry regulation compliance, must fulfil to a number of additional requirements related to the listing on public financial markets (GENT - Nasdaq).

Dr. Calabrese, on the basis of the achievements, talks about his and Gentium's experience before, during and after the implementation project, with a view to the forthcoming development goals.

Related Links:
Read the article (1356 KB)
PRMS/ACG
Gentium


1/10/2007 - EAM - Enterprise Asset Management

Pansoft, as Infor Channel Partner, is now distributor of EAM - Enterprise Asset Management solution.

Infor EAM (Enterprise Asset Management) enables manufacturers, distributors, and services organisations to save time and money by optimising maintenance resources, improving equipment and staff productivity, increasing inventory efficiency, and strengthening their ability to collect on warranty-related claims. Infor EAM reporting tools enable better decision-making to help improve future asset performance management and profitability.

Related Links:
More information on EAM


31/5/2007 - Success Stories: Gentium

Implementation and certification of the Information System in Research and Development and Production of API (Active Pharmaceutical Ingredients).

Gentium SpA is an Italian biopharmaceutical company which specializes in the discovery, research, development and production of active ingredients derived from natural sources as potential therapeutic agents.

Gentium has evolved an innovative approach to research and development focussing its activities on active ingredients which could be used in the treatment of rare diseases.
Gentium was set up in 2001 by Crinos Industria Farmacobiologica SpA (a company with over 50 years of experience in the sector). Gentium has an international agenda, being quoted on the NASDAQ (GENT) and preparing itself to increase its market potential through granting concessions for licenses on its products to international companies particularly in the US and European markets. Gentium’s four major products are: Defribotide, Heparin, Urokinase and Sulglicotide, for a total of 46 registered patents.

The integrated PRMS/ACG system has been identified as the ideal solution to satisfy Gentium’s needs not only from the point of view of satisfying the compulsory regulatory requirements but also because it offered a model seen as easily adaptable to a company with a dynamic and streamlined structure that was able to get the system up and running within a limited time and cost frame.

The advantages to Gentium arising from the implementation of PRMS/ACG are the achievement of complete operational ability within a limited time and cost frame and a minimum impact on the agile company organisation, despite the complex nature of the procedures.

Related Links:
Read the details
PRMS/ACG
Gentium


 | 1 | 2 | 
News
Our offices
Privacy
Print
Search
You need to upgrade your Flash Player
 P.IVA 02195530130 Company | Solutions | Services | References | Partners | Contacts | Italiano website by: effective